Publication Name	World Journal of Hepatology
Manuscript ID	24415
Country	China

Received	2016-01-22 10:46
Peer-Review Started	2016-01-22 18:37
To Make the First Decision	2016-02-29 15:11
Return for Revision	2016-03-01 17:19
Revised	2016-03-14 14:55
Second Decision	2016-04-13 18:05
Accepted by Journal Editor-in-Chief	2016-04-14 13:12
Accepted by Company Editor-in-Chief	2016-04-22 17:16
Articles in Press	2016-04-22 17:16
Publication Fee Transferred
Edit the Manuscript by Language Editor	2016-04-26 21:55
Typeset the Manuscript	2016-05-07 18:08
Publish the Manuscript Online	2016-05-12 10:37

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Liver resection for intermediate hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Peng-Sheng Yi, Ming Zhang, Ji-Tong Zhao and Ming-Qing Xu
Funding Agency and Grant Number
Corresponding Author	Ming-Qing Xu, MD, Department of Liver Surgery, West China Hospital, Sichuan University, Guoxue Road, Chengdu 610041, Sichuan Province, China. xumingqing0018@163.com
Key Words	Trans-catheter arterial chemoembolization; Intermediate hepatocellular carcinoma; Liver resection; Prognostic factor
Core Tip	Trans-catheter arterial chemoembolization (TACE) is recommended as the standard treatment of intermediate hepatocellular carcinoma (HCC) by the Barcelona Clinic Liver Cancer guideline, and this review investigates whether liver resection is better than TACE for intermediate HCC. Based on published studies, we compare the survival benefits and complications of liver resection and TACE for intermediate HCC. We also compare the survival benefits of liver resection in early and intermediate HCC. We find that liver resection could achieve better or at least comparable survival outcomes compared with TACE for intermediate HCC; however, we do not observe a significant difference between liver resection and TACE in terms of safety and morbidity.
Publish Date	2016-05-12 10:37
Citation	Yi PS, Zhang M, Zhao JT, Xu MQ. Liver resection for inter­mediate hepatocellular carcinoma. World J Hepatol 2016; 8(14): 607-615
URL	http://www.wjgnet.com/1948-5182/full/v8/i14/607.htm
DOI	http://dx.doi.org/10.4254/wjh.v8.i14.607

Full Article (PDF)	WJH-8-607.pdf
Full Article (Word)	WJH-8-607.doc
Manuscript File	24415-Review.doc
Answering Reviewers	24415-Answering reviewers.pdf
Audio Core Tip	24415-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	24415-Conflict-of-interest statement.pdf
Copyright License Agreement	24415-Copyright assignment.pdf
Peer-review Report	24415-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	24415-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	24415-Scientific misconduct check.pdf
Scientific Editor Work List	24415-Scientific editor work list.pdf